Randomized Trialvery high evidence
Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years.
The New England journal of medicine·February 19, 2026·PMID 41144631
Why it mattersThis provides the longest follow-up to date comparing TAVR and surgery in low-risk patients, confirming sustained equipoise in clinical outcomes and valve durability. It supports TAVR as a durable option for this population.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled